Long isoform of ErbB3 binding protein, p48, mediates protein kinase B/Akt-dependent HDM2 stabilization and nuclear localization

Experimental Cell Research

Volumn 318, Issue 2, 2012, Pages 136-143

  Kim, Chung Kwon ^a   Lee, Sang Bae ^a   Nguyen, Truong L X ^a   Lee, Kyung Hoon ^a   Um, Sung Hee ^a   Kim, Jihoe ^b   Ahn, Jee Yin ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

Akt; ErbB3 binding protein (Ebp1); HDM2; Oncogene

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 3; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P48;

ARTICLE; CANCER CELL; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; UBIQUITINATION; UPREGULATION;

EID: 82855165064     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.08.013     Document Type: Article

References (31)

1. Yoo J.Y., Wang X.W., Rishi A.K., Lessor T., Xia X.M., Gustafson T.A., Hamburger A.W. Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin. Br. J. Cancer 2000, 82:683-690.
2. Radomski N., Jost E. Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle. Exp. Cell Res. 1995, 220:434-445.
3. Ahn J.Y., Liu X., Liu Z., Pereira L., Cheng D., Peng J., Wade P.A., Hamburger A.W., Ye K. Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase. EMBO J. 2006, 25:2083-2095.
4. Liu Z., Ahn J.Y., Liu X., Ye K. Ebp1 isoforms distinctively regulate cell survival and differentiation. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10917-10922.
5. Xia X., Cheng A., Lessor T., Zhang Y., Hamburger A.W. Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation. J. Cell. Physiol. 2001, 187:209-217.
6. Squatrito M., Mancino M., Sala L., Draetta G.F. Ebp1 is a dsRNA-binding protein associated with ribosomes that modulates eIF2alpha phosphorylation. Biochem. Biophys. Res. Commun. 2006, 344:859-868.
7. Kim C.K., Nguyen T.L., Joo K.M., Nam D.H., Park J., Lee K.H., Cho S.W., Ahn J.Y. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors. Cancer Res. 2010, 70:9730-9741.
8. Momand J., Wu H.H., Dasgupta G. MDM2-master regulator of the p53 tumor suppressor protein. Gene 2000, 242:15-29.
9. Prives C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 1998, 95:5-8.
10. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
11. Brooks C.L., Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr. Opin. Cell Biol. 2003, 15:164-171.
12. Brooks C.L., Gu W. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 2006, 21:307-315.
13. Li M., Brooks C.L., Wu-Baer F., Chen D., Baer R., Gu W. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003, 302:1972-1975.
14. Zhang R., Wang H., Agrawal S. Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanisms. Curr. Cancer Drug Targets 2005, 5:43-49.
15. Chen J., Marechal V., Levine A.J. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 1993, 13:4107-4114.
16. Oliner J.D., Pietenpol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 1993, 362:857-860.
17. Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992, 69:1237-1245.
18. Shieh S.Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997, 91:325-334.
19. Maki C.G. Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2. J. Biol. Chem. 1999, 274:16531-16535.
20. Kamijo T., Weber J.D., Zambetti G., Zindy F., Roussel M.F., Sherr C.J. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:8292-8297.
21. Sharp D.A., Kratowicz S.A., Sank M.J., George D.L. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J. Biol. Chem. 1999, 274:38189-38196.
22. Li M., Brooks C.L., Kon N., Gu W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 2004, 13:879-886.
23. Mayo L.D., Donner D.B. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:11598-11603.
24. Ogawara Y., Kishishita S., Obata T., Isazawa Y., Suzuki T., Tanaka K., Masuyama N., Gotoh Y. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J. Biol. Chem. 2002, 277:21843-21850.
25. Feng J., Tamaskovic R., Yang Z., Brazil D.P., Merlo A., Hess D., Hemmings B.A. Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation. J. Biol. Chem. 2004, 279:35510-35517.
26. Meek D.W., Knippschild U. Posttranslational modification of MDM2. Mol. Cancer Res. 2003, 1:1017-1026.
27. Blattner C., Hay T., Meek D.W., Lane D.P. Hypophosphorylation of Mdm2 augments p53 stability. Mol. Cell. Biol. 2002, 22:6170-6182.
28. Okamoto K., Li H., Jensen M.R., Zhang T., Taya Y., Thorgeirsson S.S., Prives C. Cyclin G recruits PP2A to dephosphorylate Mdm2. Mol. Cell 2002, 9:761-771.
29. Gu L., Zhu N., Zhang H., Durden D.L., Feng Y., Zhou M. Regulation of XIAP translation and induction by MDM2 following irradiation. Cancer Cell 2009, 15:363-375.
30. Zhou B.P., Liao Y., Xia W., Zou Y., Spohn B., Hung M.C. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 2001, 3:973-982.
31. Tao W., Levine A.J. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:3077-3080.